Measurement of staphylococcal enterotoxin B in serum and culture supernatant with a capture enzyme-linked immunosorbent assay

Clinical and Vaccine Immunology

Volumn 14, Issue 9, 2007, Pages 1094-1101

  Cook, E ^a   Wang, X ^a   Robiou, N ^b   Fries, B C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSAMINE; LIPOPOLYSACCHARIDE; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; KIDNEY CLEARANCE; MEASUREMENT; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERUM; SHOCK; STAPHYLOCOCCUS; TRANSCYTOSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; ENTEROTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MICE; MICE, INBRED BALB C; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 34948900459     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00183-07     Document Type: Article

References (41)

1. Azuma, K., K. Koike, T. Kobayashi, T. Mochizuki, K. Mashiko, and Y. Yamamoto. 2004. Detection of circulating superantigens in an intensive care unit population. Int. J. Infect. Dis. 8:292-298.
2. Bavari, S., R. G. Ulrich, and R. D. LeClaire. 1999. Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. J. Infect. Dis. 180:1365-1369.
3. Boles, J. W., M. L. Pitt, R. D. LeClaire, P. H. Gibbs, E. Torres, B. Dyas, R. G. Ulrich, and S. Bavari. 2003. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin. Immunol. 108:51-59.
4. Casadevall, A., J. Mukherjee, and M. D. Scharff. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154:27-35.
5. Faulkner, L., A. Cooper, C. Fantino, D. M. Altmann, and S. Sriskandan. 2005. The mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine storm. J. Immunol. 175:6870-6877.
6. Ferry, T., D. Thomas, A. L. Genestier, M. Bes, G. Lina, F. Vandenesch, and J. Etienne. 2005. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin. Infect. Dis. 41:771-777.
7. Freed, R. C., M. L. Evenson, R. F. Reiser, and M. S. Bergdoll. 1982. Enzyme-linked immunosorbent assay for detection of staphylococcal enterotoxins in foods. Appl. Environ. Microbiol. 44:1349-1355.
8. Hamad, A. R., P. Marrack, and J. W. Kappler. 1997. Transcytosis of staphylococcal superantigen toxins. J. Exp. Med. 185:1447-1454.
9. Holtfreter, S., K. Bauer, D. Thomas, C. Feig, V. Lorenz, K. Roschack, E. Friebe, K. Selleng, S. Lovenich, T. Greve, A. Greinacher, B. Panzig, S. Engelmann, G. Lina, and B. M. Broker. 2004. egc-encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect. Immun. 72:4061-4071.
10. Holtfreter, S., and B. M. Broker. 2005. Staphylococcal superantigens: do they play a role in sepsis? Arch. Immunol. Ther. Exp. (Warsaw) 53:13-27.
11. Holtfreter, S., K. Roschack, P. Eichler, K. Eske, B. Holtfreter, C. Kohler, S. Engelmann, M. Hecker, A. Greinacher, and B. M. Broker. 2006. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J. Infect. Dis. 193:1275-1278.
12. Iandolo, J. J., and W. M. Shafer. 1977. Regulation of staphylococcal enterotoxin B. Infect. Immun. 16:610-616.
13. Kappler, J. W., A. Herman, J. Clements, and P. Marrack. 1992. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J. Exp. Med. 175:387-396.
14. LeClaire, R. D., and S. Bavari. 2001. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob. Agents Chemother. 45:460-463.
15. LeClaire, R. D., R. E. Hunt, and S. Bavari. 2002. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect. Immun. 70:2278-2281.
16. Ler, S. G., F. K. Lee, and P. Gopalakrishnakone. 2006. Trends in detection of warfare agents. Detection methods for ricin, staphylococcal enterotoxin B and T-2 toxin. J. Chromatogr. A 1133:1-12.
17. McCormick, J. K., J. M. Yarwood, and P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 55:77-104.
18. Miethke, T., C. Wahl, K. Heeg, B. Echtenacher, P. H. Krammer, and H. Wagner. 1992. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J. Exp. Med. 175:91-98.
19. Nagaki, M., Y. Muto, H. Ohnishi, S. Yasuda, K. Sano, T. Naito, T. Maeda, T. Yamada, and H. Moriwaki. 1994. Hepatic injury and lethal shock in galactosamine-sensitized mice induced by the superantigen staphylococcal enterotoxin B. Gastroenterology 106:450-458.
20. Nedelkov, D., and R. W. Nelson. 2003. Detection of Staphylococcal enterotoxin B via biomolecular interaction analysis mass spectrometry. Appl. Environ. Microbiol. 69:5212-5215.
21. Novick, R. P. 2003. Mobile genetic elements and bacterial toxinoses: the superantigen-encoding pathogenicity islands of Staphylococcus aureus. Plasmid 49:93-105.
22. Peruski, A. H., L. H. Johnson III, and L. F. Peruski, Jr. 2002. Rapid and sensitive detection of biological warfare agents using time-resolved fluorescence assays. J. Immunol. Methods 263:35-41.
23. Pragman, A. A., and P. M. Schlievert. 2004. Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. FEMS Immunol. Med. Microbiol. 42:147-154.
24. Rajagopalan, G., K. Iijima, M. Singh, H. Kita, R. Patel, and C. S. David. 2006. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect. Immun. 74:1284-1296.
25. Rajagopalan, G., M. M. Sen, and C. S. David. 2004. In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists. Infect. Immun. 72:6733-6737.
26. Rajagopalan, G., M. M. Sen, M. Singh, N. S. Murali, K. A. Nath, K. Iijima, H. Kita, A. A. Leontovich, U. Gopinathan, R. Patel, and C. S. David. 2006. Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock 25:647-656.
27. Rajagopalan, G., M. K. Smart, S. Cheng, C. J. Krco, K. L. Johnson, and C. S. David. 2003. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M. Tissue Antigens 62:149-161.
28. Rajagopalan, G., M. K. Smart, C. J. Krco, and C. S. David. 2002. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain. J. Immunol. 169:1774-1783.
29. Reed, S. D., J. Y. Friedman, J. J. Engemann, R. I. Griffiths, K. J. Anstrom, K. S. Kaye, M. E. Stryjewski, L. A. Szczech, L. B. Reller, G. R. Corey, K. A. Schulman, and V. G. Fowler, Jr. 2005. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol. 26:175-183.
30. Ruan, C., K. Zeng, O. K. Varghese, and C. A. Grimes. 2004. A staphylococcal enterotoxin B magnetoelastic immunosensor. Biosens. Bioelectron. 20:585-591.
31. Sasaki, T., Y. Terano, T. Shibata, H. Kawamoto, T. Kuzuguchi, E. Kohyama, T. Watanabe, T. Ohyama, and M. Gemba. 2005. Establishment of highly specific and quantitative immunoassay systems for staphylococcal enterotoxin A, B, and C using newly-developed monoclonal antibodies. Microbiol. Immunol. 49:589-597.
32. Schotte, U., N. Langfeldt, A. H. Peruski, and H. Meyer. 2002. Detection of staphylococcal enterotoxin B (SEB) by enzyme-linked immunosorbent assay and by a rapid hand-held assay. Clin. Lab. 48:395-400.
33. Swaminathan, S., W. Furey, J. Pletcher, and M. Sax. 1992. Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801-806.
34. Tempelman, L. A., K. D. King, G. P. Anderson, and F. S. Ligler. 1996. Quantitating staphylococcal enterotoxin B in diverse media using a portable fiber-optic biosensor. Anal. Biochem. 233:50-57.
35. Todaro-Luck, F., E. Reiss, R. Cherniak, and L. Kaufman. 1989. Characterization of Cryptococcus neoformans capsular glucuronoxylomannan polysaccharide with monoclonal antibodies. Infect. Immun. 57:3882-3887.
36. Ulrich, R. G., S. Sidell, T. J. Taylor, C. L. Wilhelmsen, and D. R. Franz. 2001. Textbook of military medicine: medical aspects of chemical and biological warfare. www.bordeninstitute.army.mil/cwbw/default.htm. Borden Institute, Washington, DC.
37. Vojtov, N., H. F. Ross, and R. P. Novick. 2002. Global repression of exotoxin synthesis by staphylococcal superantigens. Proc. Natl. Acad. Sci. USA 99:10102-10107.
38. Wisplinghoff, H., T. Bischoff. S. M. Tallent, H. Seifert, R. P. Wenzel, and M. B. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
39. Yarwood, J. M., J. K. McCormick, and P. M. Schlievert. 2001. Identification of a novel two-component regulatory system that acts in global regulation of virulence factors of Staphylococcus aureus. J. Bacteriol. 183:1113-1123.
40. Yarwood, J. M., and P. M. Schlievert. 2000. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J. Clin. Microbiol. 38:1797-1803.
41. Yarwood, J. M., and P. M. Schlievert. 2003. Quorum sensing in Staphylococcus infections. J. Clin. Investig. 112:1620-1625.